Allergy/Imm Medical News about metastatic melanoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible future
Expert Review of Vaccines, 10/29/09

Tosti G et al. – In Phase III clinical trials in melanoma and kidney cancer, it demonstrated an excellent safety profile with almost no toxicity. Heat–shock protein–based vaccines can be considered as a novel therapeutic approach with a promising role in cancer management.

<< Previous
The Stability of Cytadherence Proteins in Mycoplasma pneumoniae...

Next >>
Patient with neuromyelitis optica and inflammatory demyelinating...

Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy
The Oncologist, 10/30/09 Relevance Score: 70%

Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09 Relevance Score: 70%

Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma
Cancer, 10/30/09 Relevance Score: 69%

Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09 Relevance Score: 68%

Metastatic cutaneous malignant melanoma: Spectrum of imaging findings and the role of multimodality imaging
Journal of Medical Imaging and Radiation Oncology (JMIRO), 10/05/09 Relevance Score: 68%